What makes our product different?

Bromelain is a mixture of cysteine proteases extracted from pineapple stem. Its therapeutic relevance in vocal health lies in three documented mechanisms: inhibition of prostaglandin E2 and COX-2 activity (the same inflammatory pathway targeted by NSAIDs), reduction of tissue edema through fibrinolytic and kinin-modulating activity, and mucolytic action that supports mucus clearance in the upper respiratory tract.

For professional voice users, the most relevant application is post-performance recovery. Heavy vocal use causes mechanical stress on the vocal folds, triggering a localized inflammatory response and microedema that compromises phonation quality and range. Bromelain's anti-edematous mechanism directly addresses this — and unlike NSAIDs, it does so without the gastric risk profile.

The 500 mg dose in Vocalise™ reflects the range used in clinical studies demonstrating systemic anti-inflammatory effects when taken between meals, allowing intestinal absorption rather than digestive activity.

Papain is a cysteine endopeptidase that, when ingested in a fasted state and absorbed intestinally, acts systemically to degrade inflammatory protein matrices and modulate immune response. Published research in recreational athletes demonstrates that oral protease supplementation including papain significantly accelerates recovery from exercise-induced muscle damage — a mechanism directly analogous to vocal fold recovery from vocal use.

The analgesic properties of papain operate through inhibition of bradykinin — a key mediator of pain and inflammation at sites of tissue damage. For voice users experiencing laryngeal discomfort or post-performance throat inflammation, this mechanism is clinically relevant.

Papain works synergistically with bromelain in the Vocalise™ formula. Together, these two proteolytic enzymes provide broader protease coverage across inflammatory protein substrates than either would achieve alone.

Serrapeptase (serratiopeptidase) is a serine protease originally isolated from Serratia bacteria and it is the most ENT-specific enzyme in the Vocalise™ formula — and the most directly evidence-backed ingredient for vocal health applications.

The Mazzone et al. 1990 multicenter double-blind RCT enrolled 193 patients with acute and chronic otorhinolaryngological disorders. Serrapeptase demonstrated statistically significant reductions in pain, swelling, and secretion viscosity compared to placebo — across conditions including laryngitis, pharyngitis, sinusitis, and tonsillitis. These are the exact pathological presentations most relevant to professional voice users under heavy demand.

Serrapeptase's fibrinolytic activity is clinically significant: it selectively degrades non-living fibrin and inflammatory protein matrices without affecting healthy tissue, clearing the post-inflammatory debris that contributes to prolonged vocal fold swelling and stiffness after heavy use.

At 20 mg (120,000 SPU), Vocalise™ delivers serrapeptase at the dose range studied in published clinical trials. Tested against placebo

Curcumin is the primary bioactive compound in turmeric and one of the most extensively studied natural anti-inflammatory compounds. Its mechanisms are well-characterized: inhibition of NF-kB signaling, suppression of COX-2 and 5-LOX enzyme activity, and downregulation of pro-inflammatory cytokines including TNF-a and IL-6. The longstanding clinical limitation of curcumin has been poor bioavailability — standard curcumin extracts are rapidly metabolized and minimally absorbed, limiting their systemic therapeutic effect.

BCM-95® (CurcuGreen®) addresses this through a fundamentally different approach than phosphatidylcholine-based phytosomes. Rather than complexing curcumin with a carrier, BCM-95® retains the naturally occurring turmeric essential oil — specifically enriched to 45% ar-turmerone — alongside the curcuminoid complex. Ar-turmerone is a sesquiterpene ketone with its own documented anti-inflammatory and neuroprotective activity, and published pharmacokinetic research demonstrates that this whole-turmeric approach significantly enhances curcuminoid absorption compared to standard curcumin extracts.

Because BCM-95® is derived entirely from the turmeric rhizome with no synthetic carriers or excipients, it represents 100% pure turmeric — the full-spectrum bioactive profile of the plant rather than an isolated fraction. This is a meaningful distinction for a formula built around clinical transparency.

In the context of Vocalise™, BCM-95® provides the sustained systemic anti-inflammatory foundation that complements the acute-acting proteolytic enzymes — particularly relevant for voice professionals in extended performance seasons where chronic low-grade laryngeal inflammation accumulates over time. It is a trademarked ingredient.

BCM-95

Vitamin C (ascorbic acid) at 48 mg (53% DV) serves a structural role in the Vocalise™ formula. Collagen is the primary structural protein of the vocal folds, subglottic tissue, and laryngeal mucosa. Vitamin C is an essential cofactor for prolyl and lysyl hydroxylase — the enzymes responsible for collagen cross-linking and stability. Without adequate ascorbate, collagen synthesis is impaired and connective tissue integrity deteriorates.

For professional voice users, the structural integrity of the vocal folds is the physical foundation of everything. Published research confirms Vitamin C's role in supporting both collagen synthesis and the oxidative stress response following musculoskeletal tissue demand — making it a clinically relevant addition to a formula designed for high-performance vocal use.